Trupanion (TRUP)
(Delayed Data from NSDQ)
$53.50 USD
+2.61 (5.13%)
Updated Oct 16, 2024 04:00 PM ET
After-Market: $53.54 +0.04 (0.07%) 5:20 PM ET
3-Hold of 5 3
F Value A Growth C Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$53.50 USD
+2.61 (5.13%)
Updated Oct 16, 2024 04:00 PM ET
After-Market: $53.54 +0.04 (0.07%) 5:20 PM ET
3-Hold of 5 3
F Value A Growth C Momentum C VGM
Zacks News
Allstate (ALL) Continues Auto Rate Hikes to Boost Profits
by Zacks Equity Research
Allstate (ALL) reports estimated catastrophe losses of $435 million after taxes in August.
Why You Should Add Brown & Brown (BRO) Stock to Your Portfolio
by Zacks Equity Research
Solid new businesses, premium-rate increases across the majority of business lines, expansion initiatives, strategic acquisitions and a strong financial position continue to drive Brown & Brown (BRO).
CME Group (CME) to Introduce Cobalt Hydroxide Futures on Oct 23
by Zacks Equity Research
CME Group (CME) is set to address the need for a hedging instrument in the battery space with the launch of Cobalt Hydroxide futures.
Wall Street Analysts Predict a 25.01% Upside in Trupanion (TRUP): Here's What You Should Know
by Zacks Equity Research
The average of price targets set by Wall Street analysts indicates a potential upside of 25% in Trupanion (TRUP). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
CME Group (CME) to Introduce Options on Micro Gold Futures
by Zacks Equity Research
CME Group (CME) introduces options on Micro Gold Futures to cater to the growing demand for gold products.
AON Stock Jumps 14% in a Year: More Growth on the Horizon?
by Zacks Equity Research
AON is poised for long-term growth on the back of Strategy and Technology Group performance, talent investments, and improving operations in multiple regions.
Manulife (MFC) Enhances Product Suite With New Medicine Program
by Zacks Equity Research
Manulife (MFC) launches Personalized Medicine Program for Enhanced Health Care members in Canada.
Here's Why You Should Add Primerica (PRI) to Your Portfolio
by Zacks Equity Research
Higher premiums in term life insurance, increasing sales force and improving senior health business should poise Primerica (PRI) well for growth.
Here's Why You Should Hold MarketAxess' (MKTX) Stock Now
by Zacks Equity Research
MarketAxess' (MKTX) Adaptive Auto-X solution adds further strength to its suite of automated trading solutions.
Here's Why You Should Retain AMERISAFE (AMSF) Stock Now
by Zacks Equity Research
Improving retention, a high-interest rate environment and a robust balance sheet poise AMERISAFE (AMSF) well for growth.
Why Investors Are Snapping Up ProAssurance (PRA) Stock Now
by Zacks Equity Research
ProAssurance's (PRA) higher investment returns, thanks to a high interest rate environment, will keep benefiting the company's results.
MetLife (MET) Stock Rises 19.5% in 3 Months: More Room to Run?
by Zacks Equity Research
MetLife's (MET) cost-curbing initiatives are likely to lower expenses, increase efficiency and boost profit levels.
Aflac (AFL) Collaborates With LTIMindtree for Cloud Migration
by Zacks Equity Research
Aflac (AFL) selects LTIMindtree to aid it in the digital transformation journey and cloud migration.
How Are Rate Hikes Aiding Allstate (ALL) to Combat Inflation?
by Zacks Equity Research
Allstate (ALL) reports estimated catastrophe losses of $247 million after taxes in July.
Why Prudent Investors are Buying Aflac (AFL) Shares Now
by Zacks Equity Research
Aflac's (AFL) expense ratio is expected to improve significantly in 2023, dragging the combined ratio down below the year-ago level.
How Much Upside is Left in Trupanion (TRUP)? Wall Street Analysts Think 25.27%
by Zacks Equity Research
The consensus price target hints at a 25.3% upside potential for Trupanion (TRUP). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Here's What Key Metrics Tell Us About Trupanion (TRUP) Q2 Earnings
by Zacks Equity Research
While the top- and bottom-line numbers for Trupanion (TRUP) give a sense of how the business performed in the quarter ended June 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Trupanion (TRUP) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Trupanion (TRUP) delivered earnings and revenue surprises of 21.43% and 3.03%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Aflac (AFL) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Aflac (AFL) delivered earnings and revenue surprises of 11.27% and 14.47%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Employers Holdings (EIG) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Employers Holdings (EIG) delivered earnings and revenue surprises of 30% and 2.09%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Trupanion (TRUP) Moves 9.9% Higher: Will This Strength Last?
by Zacks Equity Research
Trupanion (TRUP) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Trupanion (TRUP) Reports Q1 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
The headline numbers for Trupanion (TRUP) give insight into how the company performed in the quarter ended March 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Trupanion (TRUP) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Trupanion (TRUP) delivered earnings and revenue surprises of -114.29% and 1.77%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Unum (UNM) Q1 Earnings Surpass Estimates
by Zacks Equity Research
Unum (UNM) delivered earnings and revenue surprises of 13.33% and 0.76%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Trupanion (TRUP) Surges 9.0%: Is This an Indication of Further Gains?
by Zacks Equity Research
Trupanion (TRUP) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.